drugset / Trial / NCT02327793
Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to provide a description of blood flow changes in the brain after blood pressure lowering drugs are given. This information will be used by physicians to guide blood pressure lowering therapy in stroke patients in the future.
Timeline
- Start
- 2009-06
- Primary completion
- 2015-07
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Labetalol | Small molecule | 10 mg | Intravenous |
| Subject | Labetalol | Small molecule | 20 mg | Intravenous |
| Subject | Nitroglycerin | Unknown | 0.2 mg | Other |
| Subject | Nitroglycerin | Unknown | 0.3 mg | Other |